| Cynthia Eve Wikler, MD | |
|
2500 Merced St, San Leandro, CA 94577-4201 | |
| (510) 454-1000 | |
| Not Available |
| Full Name | Cynthia Eve Wikler |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 2500 Merced St, San Leandro, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215016365 | NPI | - | NPPES |
| 00A457960 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | A45796 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Other state developments include the District of Columbia's decision to extend enrollment until April 30, New York's announcement that nearly 1 million residents enrolled in coverage and a Georgia report that only about half of the 220,000 enrollees in that state have paid their first month's premiums.
Even early stages of kidney disease come with steep medical costs, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The study found that expenses related to moderate chronic kidney disease cost Medicare tens of billions of dollars each year.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
In 2012, about 28,000 new cases of cancer in men (3.5%) and 72,000 in women (9.5%) were due to overweight or obesity in the United States alone. There is an urgent need for research that focuses on the cancer-promoting effects of obesity as it's the leading preventable cause of cancer for women and the second for men.
Many patients with chronic conditions do not take as much of their medication as they should. As a result, the effectiveness of the treatment is often suboptimal, and it also becomes more expensive. Until now, the extent to which the guidance of patients could be improved to promote the correct use of medication had been unclear.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Eve Wikler, MD 2500 Merced St, San Leandro, CA 94577-4201 Ph: (510) 454-1000 | Cynthia Eve Wikler, MD 2500 Merced St, San Leandro, CA 94577-4201 Ph: (510) 454-1000 |
News Archive
Other state developments include the District of Columbia's decision to extend enrollment until April 30, New York's announcement that nearly 1 million residents enrolled in coverage and a Georgia report that only about half of the 220,000 enrollees in that state have paid their first month's premiums.
Even early stages of kidney disease come with steep medical costs, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The study found that expenses related to moderate chronic kidney disease cost Medicare tens of billions of dollars each year.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
In 2012, about 28,000 new cases of cancer in men (3.5%) and 72,000 in women (9.5%) were due to overweight or obesity in the United States alone. There is an urgent need for research that focuses on the cancer-promoting effects of obesity as it's the leading preventable cause of cancer for women and the second for men.
Many patients with chronic conditions do not take as much of their medication as they should. As a result, the effectiveness of the treatment is often suboptimal, and it also becomes more expensive. Until now, the extent to which the guidance of patients could be improved to promote the correct use of medication had been unclear.
› Verified 8 days ago
Sharon Eileen Durousseau, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Shannon Liu-ku, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Merced Street, Hospital Building, Nicu, San Leandro, CA 94577 Phone: 510-454-1000 | |
Stacie Louise Walton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Dr. Arnold J Blustein, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1235 Harrison St, San Leandro, CA 94577 Phone: 510-352-2425 Fax: 510-352-6273 | |
Berenice M Ku, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Dr. Roxanna Aimee Martinez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 Fax: 510-547-2702 | |
Dr. Katherine M Gallagher, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1555 Doolittle Drive, Bancroft Pediatrics, San Leandro, CA 94577 Phone: 510-483-2600 |